Imaging and Laboratory Evaluation of Splenomegaly

Initial Clinical Assessment

Begin evaluation of any patient with suspected splenomegaly with abdominal ultrasound together with a complete blood count (CBC) with differential, peripheral blood smear, and a comprehensive metabolic panel that includes liver function tests; additional targeted laboratory studies should be ordered based on the clinical presentation. – American College of Radiology (ACR) & American Association for the Study of Liver Diseases (AASLD) [1][2]

Abdominal ultrasound is the recommended first‑line imaging modality for confirming and characterizing splenomegaly. – ACR [1][3]
Ultrasound provides accurate measurement of spleen size and volume, allowing quantitative assessment of splenomegaly. – ACR [1][3]
It evaluates splenic echogenicity and heterogeneity, which helps differentiate infiltrative versus normal parenchyma. – ACR 1
Perisplenic fluid collections (e.g., ascites, subphrenic abscess) are readily identified on ultrasound. – ACR [1][3]
Doppler assessment of portal and splenic vessels (flow direction, velocity, and splenic artery resistive index) can distinguish portal‑hypertension–related splenomegaly from hematologic causes. – ACR [1][3]
Detection of portal‑vein or splenic‑vein thrombosis is feasible with Doppler ultrasound, facilitating early management of portal‑hypertension etiologies. – ACR [1][3]
Ultrasound has limited sensitivity for splenic infarcts (≈ 18 %) and is less sensitive than CT or MRI for focal splenic lesions and infiltrative processes. – ACR (low‑sensitivity limitation) [1][3]

Contrast‑enhanced CT of the abdomen/pelvis should be obtained in patients presenting with acute left‑upper‑quadrant pain and/or fever; CT achieves a sensitivity of ~ 69 % for detecting acute splenic abnormalities. – ACR (moderate‑quality evidence) [4][3]
CT is indicated when ultrasound findings are inconclusive or suggest focal splenic lesions, providing superior anatomic detail. – ACR [4][1]
CT is preferred when there is clinical concern for splenic infarction, abscess formation, or vascular abnormalities (e.g., thrombosis). – ACR [4][1]3
Evaluation of associated intra‑abdominal lymphadenopathy or concurrent hepatic pathology is best performed with contrast‑enhanced CT. – ACR 1
MRI of the abdomen (with and without IV contrast) is the modality of choice for detailed characterization of splenic parenchyma, masses, infiltrative disease, and micronodularity, especially when radiation avoidance is desired. – ACR (high‑resolution imaging) [4][1]
MRI is recommended for pregnant patients or children who require cross‑sectional imaging, given its lack of ionizing radiation. – ACR 1

Abnormal liver function tests (AST, ALT, alkaline phosphatase, GGT, total bilirubin) are significantly associated with hepatic causes of splenomegaly (P < 0.01) and account for roughly 36 % of cases. – AASLD (statistically significant) 2
Non‑invasive fibrosis scores (APRI, FIB‑4, GPR) calculated from routine labs should be used to assess for advanced liver fibrosis and portal hypertension. – AASLD (clinical recommendation) 2
Thrombocytopenia on CBC suggests hypersplenism or underlying bone‑marrow pathology and is incorporated into fibrosis‑score calculations. – AASLD (clinical relevance) 2

Flow cytometry of peripheral blood (or bone‑marrow aspirate) is essential when a hematologic malignancy (e.g., leukemia, lymphoma) is suspected. – American Society of Hematology (ASH) 5
Serum protein electrophoresis should be performed when a plasma‑cell dyscrasia is in the differential diagnosis. – ASH 5
A fasting lipid profile is useful in children with suspected lysosomal storage disorders, as mixed dyslipidemia is common in acid‑sphingomyelinase deficiency. – American College of Medical Genetics (ACMG) [6][7]8
Enzyme assays for glucocerebrosidase, sphingomyelinase, and lysosomal acid lipase are required to confirm Gaucher disease, Niemann‑Pick disease, or lysosomal acid lipase deficiency, respectively. – ACMG [6][7]9

Measurement of liver span at the mid‑clavicular line is recommended; hepatomegaly demonstrates a sensitivity of ~ 60 % and specificity of ~ 44 % for advanced liver disease. – AASLD 2
The presence of hepatosplenomegaly is the most common clinical presentation of lysosomal storage diseases in children. – ACMG [6][7]8

FDG‑PET/CT is not appropriate for the initial work‑up of splenomegaly because it cannot reliably differentiate lymphoma, fungal infection, or other etiologies; its role is limited to identifying optimal biopsy targets. – ACR (guideline limitation) [1][10]